Scarritt Sciences Group Acquires TrialTech Medical
Scarritt Sciences Group Acquires TrialTech Medical
TUCSON, Ariz. and BEVERLY HILLS, Calif., Jan. 19, 2021 Scarritt Group Inc., a technology-enabled leader in the planning and execution of meetings for Investigators and Coordinators of clinical trials, today announced the acquisition of TrialTech Medical Inc., a leader in the application of cloud- based software and artificial intelligence enabled digital marketing for the recruitment of eligible subjects for clinical trials. The acquisition was completed by Scarritt Sciences Inc., an affiliate of Scarritt Group.
Beverly Hills based TrialTech is a product and services company that facilitates awareness, procures & screens subjects for new clinical trials using their unique, proprietary algorithm.